Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

Overview of attention for article published in New England Journal of Medicine, November 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

So far, Altmetric has seen 4 Google+ posts from 4 users.

#DrugUstekinumab May Ease #Crohn's #Disease. A recent research stated that, Ustekinumab is a potentially... #DrugUstekinumab…

Ustekinumab, a human antibody used to treat arthritis, significantly induces response and remission ... Ustekinumab, a human…

#Ustekinumab as Induction and Maintenance Therapy for #Crohn’s Disease — NEJM #Ustekinumab as Induction and Maintenance Therapy…

#Ustekinumab as Induction and Maintenance Therapy for #Crohn’s Disease #Ustekinumab as Induction and Maintenance Therapy for #Cro…

This page shows the most recent Google+ posts that mention this research output. Click here to find out how to access more activity.